[1. Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci [Internet]. 30 September 2021;26:82. Available at: https://pubmed.ncbi.nlm.nih.gov/34759999]Search in Google Scholar
[2. Hardenbrook NJ, Zhang P. A structural view of the SARS-CoV-2 virus and its assembly. Curr Opin Virol. 2022;52:123–34.]Search in Google Scholar
[3. Samavati L, Uhal BD. ACE2, Much More Than Just a Receptor for SARS-COV-2. Vol 10, Frontiers in Cellular and Infection Microbiology. 2020.]Search in Google Scholar
[4. Zeinali T, Faraji N, Joukar F et al. Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm. Microb Pathog [Internet]. 2022;105704. Available at: https://www.sciencedirect.com/science/article/pii/S0882401022003175]Search in Google Scholar
[5. Anastassopoulou C, Gkizarioti Z, Patrinos GP, Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics [Internet]. 2020;14(1):40. Available at: https://doi.org/10.1186/s40246-020-00290-4]Search in Google Scholar
[6. Yaghubi T, Shakoori V, Nasiri S et al. Clinical characteristics and outcomes of COVID-19 patients with a history of cardiovascular disease. J Curr Biomed Reports. 2022.]Search in Google Scholar
[7. Reddy RK, Charles WN, Sklavounos A et al. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J Med Virol. Februarie 2021;93(2):1045-56.]Search in Google Scholar
[8. Eastin C, Eastin T. Clinical Characteristics of Coronavirus Disease 2019 in China: Guan W, Ni Z, Hu Y, et al. N Engl J Med. 2020 Feb 28 [Online ahead of print] DOI: 10.1056/NEJMoa2002032. J Emerg Med [Internet]. 2020/06/03. April 2020;58(4):711-2. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266766/]Search in Google Scholar
[9. Rossato M, Russo L, Mazzocut S et al. Current smoking is not associated with COVID-19. The European respiratory journal. 2020, 55.]Search in Google Scholar
[10. Hopkinson NS, Rossi N, El-Sayed Moustafa J et al. Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax. Julie 2021;76(7):714-22.]Search in Google Scholar
[11. Yu X, Sun X, Cui P et al. Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China. Transbound Emerg Dis. Julie 2020;67(4):1697–707.]Search in Google Scholar
[12. Gülsen A, Yigitbas BA, Uslu B et al. The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis. Pulm Med [Internet]. 08 September 2020;2020:7590207. Available at: https://pubmed.ncbi.nlm.nih.gov/32963831]Search in Google Scholar
[13. Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020;75:107–8.]Search in Google Scholar
[14. West R. Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychol Health. 2017/05/28. Augustus 2017;32(8):1018–36.]Search in Google Scholar
[15. Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review. Int J Environ Res Public Health. Mei 2018;15(5).]Search in Google Scholar
[16. Liu W, Tao Z-W, Wang L et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). Mei 2020;133(9):1032-8.]Search in Google Scholar
[17. Alqahtani JS, Aldhahir AM, Oyelade T et al. Smoking cessation during COVID-19: the top to-do list. NPJ Prim care Respir Med. Mei 2021;31(1):22.]Search in Google Scholar
[18. Ho KS, Narasimhan B, Sheehan J et al. Controversy over smoking in COVID-19-A real world experience in New York city. J Med Virol. Julie 2021;93(7):4537–43.]Search in Google Scholar
[19. Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. Junie 2021;116(6):1319–68.]Search in Google Scholar
[20. Usman MS, Siddiqi TJ, Khan MS et al. Is there a smoker’s paradox in COVID-19? BMJ evidence-based Med. Desember 2021;26(6):279–84.]Search in Google Scholar
[21. Khalili P, Ayoobi F, Mohamadi M et al. Effect of opium consumption on cardiovascular diseases – a cross-sectional study based on data of Rafsanjan cohort study. BMC Cardiovasc Disord [Internet]. 2021;21(1):2. Available at: https://doi. org/10.1186/s12872-020-01788-4]Search in Google Scholar
[22. Mehrabi S, Delavari A, Moradi G et al. Smoking among 15- to 64-Year-Old Iranian People in 2005. irje [Internet]. 01 September 2007;3(1):1–9. Available at: http://irje.tums.ac.ir/article-1-165-en.html]Search in Google Scholar
[23. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 15 Februarie 2020;395(10223):497–506. Available at: https://doi.org/10.1016/S0140-6736(20)30183-5]Search in Google Scholar
[24. Chen Q, Zheng Z, Zhang C et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection [Internet]. 2020/04/28. Augustus 2020;48(4):543–51. Available at: https://pubmed.ncbi. nlm.nih.gov/32342479]Search in Google Scholar
[25. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). Maart 2020;395(10229):1054–62.]Search in Google Scholar
[26. Alqahtani JS, Oyelade T, Aldhahir AM et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147.]Search in Google Scholar
[27. Samet JM. Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19. Nicotine Tob Res [Internet]. 01 Desember 2020;22(Supplement_1):S93–5. Available at: https://doi.org/10.1093/ntr/ntaa187]Search in Google Scholar
[28. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. Augustus 2020;15(5):845–52.]Search in Google Scholar
[29. Zureik M, Baricault B, Vabre C et al. Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France. medRxiv [Internet]. 01 Januarie 2020;2020.07.28.20160630. Available at: http://medrxiv.org/content/early/2020/07/30/2020.07.28.20160630.abstract]Search in Google Scholar
[30. Farsalinos K, Niaura R, Le Houezec J et al. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicology reports. 2020,7,658-63.]Search in Google Scholar
[31. Oakes JM, Fuchs RM, Gardner JD et al. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. November 2018;315(5):R895-906.]Search in Google Scholar
[32. Yue X, Basting TM, Flanagan TW et al. Nicotine Downregulates the Compensatory Angiotensin-Converting Enzyme 2/Angiotensin Type 2 Receptor of the Renin–Angiotensin System. Annal Am Thorac Soc, 2018;15, bl S126-7.]Search in Google Scholar
[33. Qeadan F, Mensah NA, Tingey B et al. The association between opioids, environmental, demographic, and socioeconomic indicators and COVID-19 mortality rates in the United States: an ecological study at the county level. Arch Public Heal [Internet]. 2021;79(1):101. Available at: https://doi. org/10.1186/s13690-021-00626-z]Search in Google Scholar
[34. Riahi T, Sadeghzadeh-Bazargan A, Shokri S et al. The effect of opium on severity of COVID-19 infection:An original study from Iran. Med J Islam Repub Iran. 2021;35:115.]Search in Google Scholar
[35. Chadzinska M, Kolaczkowska E, Seljelid R, Plytycz B. Morphine modulation of peritoneal inflammation in Atlantic salmon and CB6 mice. J Leukoc Biol [Internet]. 01 Mei 1999;65(5):590-6. Available at: https://doi.org/10.1002/jlb.65.5.590]Search in Google Scholar
[36. Roy S, Loh HH. Effects of opioids on the immune system. Neurochem Res. November 1996;21(11):1375-86.]Search in Google Scholar
[37. Dolati-Somarin A, Abd-Nikfarjam B. The Reasons for Higher Mortality Rate in Opium Addicted Patients with COVID-19: A Narrative Review. Iran J Public Health. Maart 2021;50(3):470-9.]Search in Google Scholar
[38. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am. Maart 1992;76(2):333–53.]Search in Google Scholar
[39. Fang X, Li S, Yu H et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY) [Internet]. 2020/07/13. 13 Julie 2020;12(13):12493–503. Available at: https://pubmed.ncbi.nlm.nih.gov/32658868]Search in Google Scholar